UNSPSC 85621701: Revision of infusion device in endocrine gland, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in endocrine gland, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0GWS43Z

UNSPSC 85621701 Revision of infusion device in endocrine gland, percutaneous endoscopic approach is a Commodity code that shows no relevant recent state and local procurement activity. The six recent opportunities posted between July and September 2026 and tagged under this code involve independent medical evaluations for pension disability determinations, surgical benefit carve-outs, occupational medical surveillance, specialty and emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—none of which align with the endocrine-device revision services the code nominally describes. The mismatch suggests either systematic mis-tagging by issuing bodies or that this code is not actively used for state and local medical device procurement.

No representative recent opportunities under this code warrant pursuit. State and local procurement offices should verify their internal UNSPSC categorization practices if they intend to solicit endocrine device services; the current activity under this code does not reflect the commodity it names.